Nautilus Biotechnology, Inc. Logo

Nautilus Biotechnology, Inc. (NAUT)

NASDAQ

Currency in USD
3.24
+0.64 (+24.62%)

Delayed Data

Oct 23, 2026, 01:30 PM

Day's Range

2.57
3.26

52 wk Range

0.8410
4.31

Profile - NAUT - Nautilus Biotechnology, Inc.

Profile

Mic Code

XNGS

Sector

Healthcare

Industry

Biotechnology

Employees

127


Nautilus Biotechnology, Inc. is a life sciences company focused on proteomics, the large-scale study of proteins and their functions. Nautilus Biotechnology develops a platform technology designed to quantify and analyze the human proteome with high resolution, combining instrumentation, consumables, software, and analysis tools into an integrated workflow. Its current products and systems support single-molecule protein analysis and multi-cycle proteome mapping, serving research-oriented markets in biotechnology, pharmaceuticals, and academic science. The company’s platform is intended to help scientists examine protein complexity more deeply, supporting applications in biomedical research, disease biology, and drug discovery. Headquartered in Seattle, Washington, with research and development operations in San Carlos, California, Nautilus Biotechnology operates as a development-stage company in the life sciences tools segment.

Profile Details

Type

Common Stock

Address

2701 Eastlake Avenue East

City

Seattle

State

WA

Zip

98102

Country

United States

Phone

206 333 2001

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.